These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 38081559

  • 1. Understanding the impact of mannitol on physical stability and aerosolization of spray-dried protein powders for inhalation.
    Arte KS, Tower CW, Mutukuri TT, Chen Y, Patel SM, Munson EJ, Tony Zhou Q.
    Int J Pharm; 2024 Jan 25; 650():123698. PubMed ID: 38081559
    [Abstract] [Full Text] [Related]

  • 2. Understanding the Impact of Protein-Excipient Interactions on Physical Stability of Spray-Dried Protein Solids.
    Chen Y, Ling J, Li M, Su Y, Arte KS, Mutukuri TT, Taylor LS, Munson EJ, Topp EM, Zhou QT.
    Mol Pharm; 2021 Jul 05; 18(7):2657-2668. PubMed ID: 34096731
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Protection of hydrophobic amino acids against moisture-induced deterioration in the aerosolization performance of highly hygroscopic spray-dried powders.
    Yu J, Chan HK, Gengenbach T, Denman JA.
    Eur J Pharm Biopharm; 2017 Oct 05; 119():224-234. PubMed ID: 28655664
    [Abstract] [Full Text] [Related]

  • 8. The influence of storage relative humidity on aerosolization of co-spray dried powders of hygroscopic kanamycin with the hydrophobic drug rifampicin.
    Momin MAM, Tucker IG, Das SC.
    Drug Dev Ind Pharm; 2019 Jul 05; 45(7):1205-1213. PubMed ID: 30990097
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Development and characterization of a spray-dried inhalable ciprofloxacin-quercetin co-amorphous system.
    Alhajj N, O'Reilly NJ, Cathcart H.
    Int J Pharm; 2022 Apr 25; 618():121657. PubMed ID: 35288220
    [Abstract] [Full Text] [Related]

  • 15. Characterization of excipient enhanced growth (EEG) tobramycin dry powder aerosol formulations.
    Hassan A, Farkas D, Longest W, Hindle M.
    Int J Pharm; 2020 Dec 15; 591():120027. PubMed ID: 33130220
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Design, physicochemical characterization, and optimization of organic solution advanced spray-dried inhalable dipalmitoylphosphatidylcholine (DPPC) and dipalmitoylphosphatidylethanolamine poly(ethylene glycol) (DPPE-PEG) microparticles and nanoparticles for targeted respiratory nanomedicine delivery as dry powder inhalation aerosols.
    Meenach SA, Vogt FG, Anderson KW, Hilt JZ, McGarry RC, Mansour HM.
    Int J Nanomedicine; 2013 Dec 15; 8():275-93. PubMed ID: 23355776
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.